| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.35B | -2.3% |
| Cost of Revenue | $2.81B | -1.7% |
| Gross Profit | $548.4M | -4.8% |
| R&D Expense | $13.9M | +6.9% |
| SG&A Expense | $198.0M | -3.0% |
| Operating Income | $103.1M | -29.8% |
| Pre-tax Income | $33.1M | -60.3% |
| Income Tax | $6.2M | -74.6% |
| Net Income | $26.9M | -49.3% |
| EPS (Basic) | $0.52 | -45.3% |
| EPS (Diluted) | $0.51 | -45.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $289.6M | -9.6% |
| Accounts Receivable | $375.0M | +9.1% |
| Inventory | $539.3M | +1.0% |
| Current Assets | $1.01B | -4.3% |
| Total Assets | $3.98B | -3.1% |
| Current Liabilities | $744.9M | +5.8% |
| Long-term Debt | $1.41B | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $265.8M | +69.0% |
| Investing Cash Flow | -$138.3M | -161.0% |
| Financing Cash Flow | -$159.3M | -48.2% |
| Total Liabilities |
| $2.43B |
| -0.4% |
| Stockholders' Equity | $1.55B | -7.0% |